VBL Therapeutics Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $145M

  • Investors
  • 3

VBL Therapeutics General Information

Description

Vascular Biogenics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumor indications for recurrent glioblastoma, an aggressive form of brain cancer. The company is also engaged in conducting a program targeting anti-inflammatory diseases, based on the use of Lecinoxoid platform technology. The product brands of the company include VTS, Vascular Targeting Systems, Vbl, Vascular Biogenics And Vascular Therapeutics.

Contact Information

Website
www.vblrx.com
Formerly Known As
Vascular Biogenics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 8 HaSatat Street
  • Modiin 7178106
  • Israel
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 8 HaSatat Street
  • Modiin 7178106
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VBL Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 16-Oct-2023 $145M Completed Generating Revenue
11. Grant 06-Oct-2021 Completed Generating Revenue
10. 2PO 13-Apr-2021 Completed Generating Revenue
9. PIPE 13-May-2020 Completed Generating Revenue
8. Secondary Transaction - Open Market Completed Generating Revenue
7. PIPE 13-May-2020 Completed Generating Revenue
6. Secondary Transaction - Open Market 11-Feb-2017 Completed Product Development
5. 2PO 07-Jun-2016 Completed Generating Revenue
4. Secondary Transaction - Open Market 11-Feb-2016 $153M Completed Product Development
3. IPO 31-Jul-2014 $40M $153M Completed Product Development
To view VBL Therapeutics’s complete valuation and funding history, request access »

VBL Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Vascular Biogenics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and c
Drug Discovery
Modiin, Israel
7 As of 2022

Emeryville, CA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

VBL Therapeutics Competitors (36)

One of VBL Therapeutics’s 36 competitors is Dynavax Technologies, a Formerly VC-backed company based in Emeryville, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dynavax Technologies Formerly VC-backed Emeryville, CA
VBI Vaccines Corporation Cambridge, MA
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Ayala Pharmaceuticals Corporation Wilmington, DE
Amarantus BioScience Holdings Formerly Accelerator/Incubator backed New York, NY
You’re viewing 5 of 36 competitors. Get the full list »

VBL Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VBL Therapeutics Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
GlenRock Israel Growth/Expansion Minority
JJD Holdings Corporation Minority
Angel (individual) Minority
Pitango Venture Capital Venture Capital Minority
Teva Pharmaceutical Industries Corporation Minority
You’re viewing 5 of 6 investors. Get the full list »

VBL Therapeutics Acquisitions (1)

VBL Therapeutics’s most recent deal was a Reverse Merger with Notable Labs for . The deal was made on 16-Oct-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Notable Labs 16-Oct-2023 Reverse Merger Drug Discovery
To view VBL Therapeutics’s complete acquisitions history, request access »

VBL Therapeutics ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Commercial Services

Industry

Rank

Percentile

Business Support Services

Subindustry

Rank

Percentile

To view VBL Therapeutics’s complete esg history, request access »

VBL Therapeutics FAQs

  • When was VBL Therapeutics founded?

    VBL Therapeutics was founded in 2000.

  • Where is VBL Therapeutics headquartered?

    VBL Therapeutics is headquartered in Modiin, Israel.

  • What is the size of VBL Therapeutics?

    VBL Therapeutics has 7 total employees.

  • What industry is VBL Therapeutics in?

    VBL Therapeutics’s primary industry is Drug Discovery.

  • Is VBL Therapeutics a private or public company?

    VBL Therapeutics is a Private company.

  • What is the current valuation of VBL Therapeutics?

    The current valuation of VBL Therapeutics is .

  • What is VBL Therapeutics’s current revenue?

    The current revenue for VBL Therapeutics is .

  • How much funding has VBL Therapeutics raised over time?

    VBL Therapeutics has raised $232M.

  • Who are VBL Therapeutics’s investors?

    GlenRock Israel, JJD Holdings, , Pitango Venture Capital, and Teva Pharmaceutical Industries are 5 of 6 investors who have invested in VBL Therapeutics.

  • Who are VBL Therapeutics’s competitors?

    Dynavax Technologies, VBI Vaccines, Adaptimmune Therapeutics, Ayala Pharmaceuticals, and Amarantus BioScience Holdings are some of the 36 competitors of VBL Therapeutics.

  • When was VBL Therapeutics acquired?

    VBL Therapeutics was acquired on 16-Oct-2023.

  • Who acquired VBL Therapeutics?

    VBL Therapeutics was acquired by Notable Labs.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process